Fosinopril sodium - Generic Drug Details

What are the generic sources for fosinopril sodium and what is the scope of patent protection?

Fosinopril sodium is the generic ingredient in four branded drugs marketed by Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Bristol Myers Squibb, Ani Pharms, Aurobindo Pharma, Avet Lifesciences, Mylan, Sandoz, and Sun Pharm Inds Ltd, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium. Seven suppliers are listed for this compound.

Summary for fosinopril sodium

US Patents:	0
Tradenames:	4
Applicants:	17
NDAs:	22
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	111
Clinical Trials:	5
Patent Applications:	2,954
Drug Prices:	Drug price trends for fosinopril sodium
What excipients (inactive ingredients) are in fosinopril sodium?	fosinopril sodium excipients list
DailyMed Link:	fosinopril sodium at DailyMed

See drug prices for fosinopril sodium

See drug sales revenues for fosinopril sodium

Recent Clinical Trials for fosinopril sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ruijin Hospital	Phase 4
Zhongda Hospital	Phase 4
The First Affiliated Hospital of Anhui Medical University	Phase 4

See all fosinopril sodium clinical trials

Pharmacology for fosinopril sodium

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Medical Subject Heading (MeSH) Categories for fosinopril sodium

Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for fosinopril sodium

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for fosinopril sodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076483-001	Apr 23, 2004	AB	RX	No	No
Avet Lifesciences	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	079025-001	Sep 17, 2010		DISCN	No	No
Aurobindo Pharma	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	079245-002	Jul 9, 2009	AB	RX	No	Yes
Teva	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	076945-002	Jul 5, 2006		DISCN	No	No
Aurobindo Pharma Ltd	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	091163-003	Mar 30, 2011	AB	RX	No	No
Mylan	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	077705-002	Aug 14, 2006		DISCN	No	No

Expired US Patents for fosinopril sodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-002	May 16, 1991
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-003	May 16, 1991
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-003	May 16, 1991
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-004	Mar 28, 1995
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-004	Mar 28, 1995
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-004	Mar 28, 1995